Facial/body flushing when first injected Injection site irritation and/or rash Joint and/or muscle pain Fatigue Pain and swelling after repeated shots to the same injection site- (rotate injection site ) In rare cases, some patients have experienced mild hypertension Water retention Warnings and precautions: CJC1295 and Ipamoralin peptides are banned by WADA (world anti-doping agency) for uses in sports CJC1295 may be mitogenic, if patient is prone to cancer and/or have cancer, use with caution CJC1295 may mask symptoms of hypothyroidism, make sure to test thyroid hormone levels (Free and Total T3, T4, TSH and thyroid antibodies) CJC1295 can cause Congestive Heart Failure, Do Not Use if you have a history of cardiac complications CJC1295 is a growth hormone releasing hormone (GHRH) analog= growth hormone mimetic
HEDISON: Innovations in the Field of Cosmetics DR
(8) The study focused on the livers capacity to synthesize urea-N (CUNS), which may serve as an indicator of the organs ability to process nitrogen
No destinado para uso humano
Peptides such as Sermorelin and Ipamorelin stimulate growth hormone production, essential for regulating metabolism and energy
doi: 10.1371/journal.pbio.3001948 312